Description
SURGICEL HEMOSTAT/CYCLOPHOSPHAMIDE
First action · last action
2012-06-08 · 2012-06-08
Transactions
1
First transaction's obligation
$28,247
Base + all options value (sum of deltas)
$28,247
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-06-08+$28,247= $28,247
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-06-08 | +$28,247 | $28,247 | SURGICEL HEMOSTAT/CYCLOPHOSPHAMIDE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VMJLFQE5U511)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24225P1011 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $4,853 | FY2025 |
| 36C24825P0474 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,859 | FY2025 |
| 36C25024P1401 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $16,500 | FY2024 |
| 36E79724D0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C25024P0630 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $20,786 | FY2024 |
| 36C25024P0413 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $5,196 | FY2024 |
Other recipients under 6505 from 580-HOUSTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0353 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 580-HOUSTON | $5,477 | FY2013 |
| VA25613P0134 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $8,806 | FY2013 |
| VA25612P2546 | MCKESSON PLASMA AND BIOLOGICS LLC | 580-HOUSTON | $10,147 | FY2012 |
| VA25612P2560 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $9,088 | FY2012 |
| VA25612F2494 | ACTELION PHARMACEUTICALS US, INC. | 580-HOUSTON | $4,293 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612P1088_3600_-NONE-_-NONE- · retrieved 2026-09-26.